We also demonstrated that the silencing of XIAP in high XIAP-expressing and MYCN-amplified neuroblastoma cells resulted in significant apoptosis, suggesting the addiction and dependency on XIAP for survival, thus highlighting the potential of targeting XIAP as a treatment strategy for high-risk neuroblastoma. This evidence concerns the gene MYCN and neuroblastoma.